A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma-Reference-Cited by-同舟云学术

A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma

Published:2024-03-17 Issue:5-6 Volume:29 Page:768-784
ISSN:1360-8185
Container-title:Apoptosis
language:en
Short-container-title:Apoptosis

Author:

Zhang Sidi,Guo Hanyao,Wang Hongyu,Liu Xiaopeng,Wang Meixia,Liu Xiaoyu,Fan Yumei,Tan Ke

Funder

Innovation and Entrepreneurship Training Program for Undergraduates

Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology

Hebei Province Higher Education Scientific Research Special Task Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10495-024-01945-6.pdf

Reference39 articles.

1. Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391(10127):1301–1314

2. Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

3. Petrick JL et al (2020) International trends in hepatocellular carcinoma incidence, 1978–2012. Int J Cancer 147(2):317–330

4. Yan T et al (2022) The advanced development of molecular targeted therapy for hepatocellular carcinoma. Cancer Biol Med 19(6):802–817

5. Ruan L et al (2020) Mitochondria-associated proteostasis. Annu Rev Biophys 49:41–67

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analyses;Cancer Letters;2024-11